CL2014000498A1 -
Heterocyclic compounds, selective inhibitors of class I pi3k isoforms; pharmaceutical composition that includes them; and method for treating a selected cancer disorder, an anti-inflammatory disease or an autoimmune disease.
- Google Patents
Heterocyclic compounds, selective inhibitors of class I pi3k isoforms; pharmaceutical composition that includes them; and method for treating a selected cancer disorder, an anti-inflammatory disease or an autoimmune disease.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infinity Pharmaceuticals IncfiledCriticalInfinity Pharmaceuticals Inc
Publication of CL2014000498A1publicationCriticalpatent/CL2014000498A1/en
CL2014000498A2011-08-292014-02-28
Heterocyclic compounds, selective inhibitors of class I pi3k isoforms; pharmaceutical composition that includes them; and method for treating a selected cancer disorder, an anti-inflammatory disease or an autoimmune disease.
CL2014000498A1
(en)
Heterocyclic compounds, selective inhibitors of class I pi3k isoforms; pharmaceutical composition that includes them; and method for treating a selected cancer disorder, an anti-inflammatory disease or an autoimmune disease.
Compounds derived from c4-monomethyl triterpenoids; pharmaceutical composition that includes them; and method to treat or prevent a disease or disorder.
Compounds derived from substituted (2-methyl-3-phenylphenyl) methoxy, interaction inhibitors pd-1 / protein pd-l1 / protein; pharmaceutical composition comprising them; and its use to treat an infectious disease or cancer.
Thiophene fused tricyclic derivative compounds, janus kinase inhibitors (jak); pharmaceutical composition that includes them; method to inhibit the activity of jak1; method to treat an autoimmune disease, a cancer, a myeloproliferative disorder and an inflammatory disease, among other diseases.
Compounds derived from 3-pyrimidin-4-yl-oxazolidin-2-one and their salts, as inhibitors of the mutant idh proteins; pharmaceutical composition that includes them, useful for the treatment of disorders of cell proliferation such as cancer.
Tricyclic compounds that inhibit the kinase pi3 (pi3k); pharmaceutical composition that includes them; method to treat cancer; and its use for the treatment of cancer.
2-HYDROXY-1- {4 - [(4-PHENYLPHENYL) CARBONYL] PIPERAZIN-1-YL} ETHAN-1-ON DERIVATIVES AND RELATED COMPOUNDS LIKE FATHERIC ACID SYNTHASE (PHASN) INHIBITORS FOR TREATMENT
Compounds derived from amino substituted imidazopyridazines, kinase inhibitors, mknk2; Preparation method; intermediary compounds and their use; pharmaceutical composition; pharmaceutical combination; and its use for the treatment of cancer.